Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Analabs Resources BhdXKLS:7083 66 Debt-to-EBITDA is 2.29 as of Apr. 2026, which is 19% below its 10-year median of 2.81. GuruFocus rates XKLS:7083 with a GF Score™ of 66/100 and a GF Value™ of RM1.53 (Modestly Overvalued). The stock has 11 warning signs investors should review. Among 1,237 Chemicals companies, Analabs Resources Bhd ranks worse than 64.83% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Analabs Resources Bhd's Debt-to-EBITDA or its related term are showing as below:
XKLS:7083'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.74 Med: 2.81 Max: 4.05
Current: 3.46
During the past 13 years, the highest Debt-to-EBITDA Ratio of Analabs Resources Bhd was 4.05. The lowest was 0.74. And the median was 2.81.
XKLS:7083's Debt-to-EBITDA is ranked worse than 64.83% of 1237
companies
in the Chemicals industry
Industry Median: 2.15
vs XKLS:7083: 3.46
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Analabs Resources Bhd Debt-to-EBITDA Related Terms
Analabs Resources Bhd Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Analabs Resources Bhd's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7083 vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Analabs Resources Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Analabs Resources Bhd Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Analabs Resources Bhd's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Analabs Resources Bhd's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Apr. 2026) EBITDA data.
Analabs Resources Bhd (XKLS:7083) has a Debt-to-EBITDA of 2.29 as of Apr. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Analabs Resources Bhd. This is 19% below median its historical median of 2.81. Over the past decade, Analabs Resources Bhd's Debt-to-EBITDA has ranged from 0.74 to 4.05. According to the industry distribution chart, Analabs Resources Bhd ranks #802 out of 1237 companies in the Chemicals industry, placing it in the top 64.8%.
Is Analabs Resources Bhd's Debt-to-EBITDA too high?
Analabs Resources Bhd's current Debt-to-EBITDA of 2.29 is 19% below median its 10-year median of 2.81. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 4.05. The Chemicals industry median Debt-to-EBITDA is 2.15. Analabs Resources Bhd's value of 2.29 is 6.5% above this industry median. Based on the distribution chart, Analabs Resources Bhd ranks #802 out of 1237 companies in the Chemicals industry, which is below the industry midpoint. Overall, Analabs Resources Bhd has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Analabs Resources Bhd's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Analabs Resources Bhd ranks #802 out of 1237 companies for Debt-to-EBITDA. This places Analabs Resources Bhd in the lower half of its industry. The industry median Debt-to-EBITDA is 2.15. Analabs Resources Bhd's value of 2.29 is 6.5% above this benchmark. Historically, Analabs Resources Bhd's own Debt-to-EBITDA has ranged from 0.74 to 4.05 over the past decade. While the company's 10-year median is 2.81 vs. the industry median of 2.15, Analabs Resources Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.15, based on 1,237 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Analabs Resources Bhd's current Debt-to-EBITDA of 2.29 is 6.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Analabs Resources Bhd. For the Chemicals industry, the median Debt-to-EBITDA is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Analabs Resources Bhd's current Debt-to-EBITDA is 2.29, which is 19% below median its own 10-year median of 2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Analabs Resources Bhd stock overvalued right now?
Based on GuruFocus' analysis, Analabs Resources Bhd (XKLS:7083) is currently considered Modestly Overvalued. The stock's GF Value™ is RM1.53, compared to a current price of RM1.75 — trading 14.4% above its estimated fair value. The current Debt-to-EBITDA is 2.29, which is 19% below median its 10-year median of 2.81 and 6.5% above the Chemicals industry median of 2.15. Analabs Resources Bhd's overall GF Score™ is 66/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Analabs Resources Bhd (XKLS:7083), the current Debt-to-EBITDA is 2.29 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Analabs Resources Bhd (XKLS:7083) Overvalued in 2026?
Based on GuruFocus' analysis, Analabs Resources Bhd stock appears to be overvalued.
The current stock price of RM1.75 is trading 14.4% above its estimated GF Value™ of RM1.53.
GuruFocus considers Analabs Resources Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:7083:
Debt-to-EBITDA: 2.29 (19% below median its 10-year median of 2.81)
GF Value™: RM1.53 vs. price of RM1.75 (14.4% above fair value)
Industry Position: 6.5% above the Chemicals median (#802 of 1237)
No single metric tells the full story. See the XKLS:7083 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Analabs Resources Bhd is a Malaysia-based company engaged in the businesses of investment holding and the provision of management services. It has five business segments, which include: Manufacturing, formulation, and sale of resin, chemicals, and building materials; Recovery and sale of recycled products; Contract work, pipe laying, and rehabilitation; Culture and sale of prawns; Investment holding and property letting, and asset and portfolio management. The company earns the majority of its revenue from the manufacturing, formulation, and sale of resin, chemicals, and building materials. Geographically, the company derives its maximum revenue from Malaysia and the rest from Singapore.
66GF Score
Get the complete analysis for XKLS:7083
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7083 has been successfully added to your 
